日本薬学会第135年会(神戸)

3月27日(金)　9:15～11:30 / 13:00～17:50　Q会場兵庫医療大学　P棟　2F　オクタホール

IMS

International Symposium for Medicinal Sciences

International Symposium for Medicinal Sciences

オーガナイザー：YOKOYAMA Yuusaku

IMS-PL-1

Addressing Healthcare Challenges Posed by an Aging Global Population through Innovative Regenerative Medicine Technologies and Advances in Regulatory Strategies

Addressing Healthcare Challenges Posed by an Aging Global Population through Innovative Regenerative Medicine Technologies and Advances in Regulatory Strategies

シンポジスト： ○VAN BOKKELEN Gil

IMS-PL-2

Antibody-Cytokine Fusion Proteins: From the Bench to the Clinic

Antibody-Cytokine Fusion Proteins: From the Bench to the Clinic

シンポジスト： ○NERI Dario

IMS-IL-1

Paradigm Shift in Drug Discovery & Development Model

Paradigm Shift in Drug Discovery & Development Model

シンポジスト： ○MASUYA Keiichi

IMS-IL-2

Development of Novel Antiangiogenic Agents for the Treatment of Retinal Neovascularization

Development of Novel Antiangiogenic Agents for the Treatment of Retinal Neovascularization

シンポジスト： ○SUH Young-Ger

IMS-IL-3

India’s Role in the Global Innovation?Past and Future

India’s Role in the Global Innovation?Past and Future

シンポジスト： ○BHATTACHARYA Swapan

IMS-IL-4

Progress toward Identification and Development of Therapeutics in Protein Homeostasis

Progress toward Identification and Development of Therapeutics in Protein Homeostasis

シンポジスト： ○CLAIBORNE Christopher

IMS-P1

Chemical Library of Daiichi-Sankyo and Open Innovation with the Chemical Library

Chemical Library of Daiichi-Sankyo and Open Innovation with the Chemical Library

シンポジスト： ○SOGA Tsunehiko

IMS-P2

Establishment of Rapid and Practical Reaction Condition Screening System: Advanced Technology Using a Combination of High Throughput Synthesis and Automated Analysis System

Establishment of Rapid and Practical Reaction Condition Screening System: Advanced Technology Using a Combination of High Throughput Synthesis and Automated Analysis System

シンポジスト： ○TAYA Naohiro、 ARAI Ryosuke、 KUSHIBE Chie、 MASUDA Kei、 SASAKI Shinobu、 MIWA Katsuhiko、 NOMURA Izumi

IMS-P3

Synthetic and Cheminformatic Exploration of Macrocyclic and Peptidomimetic Medicinal Chemistry Space

Synthetic and Cheminformatic Exploration of Macrocyclic and Peptidomimetic Meidicinal Chemistry Space

シンポジスト： MULLER Gerhard、 BENNINGSHOF Jorg、 VAN MEURS Pauline、 WEGERT Anita、 VAN DEN HEUVEL Joyce、 VAN ASSEMA Sander、 ○MORITA Norimasa、 STUMPFE Dagmar、 DE LA VEGA DE LEON Antonio、 FURTMANN Norbert、 DIMOVA Dilyana、 BAJORATH Jurgen

IMS-P4

Unexpected Dissemination Patterns in Lymphoma Progression Revealed by Serial Lymph Node Imaging in Mouse

Unexpected Dissemination Patterns in Lymphoma Progression Revealed by Serial Lymph Node Imaging in Mouse

シンポジスト： ○ITO Ken、 SMITH Bryan、 PARASHURAMA Natesh、 GAMBHIR Sanjiv Sam

IMS-P5

NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes

NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes

シンポジスト： ○ITO Daisuke、 ADAMS Drew J.、 REES Matthew G.、 SEASHORE-LUDLOW Brinton、 PUYANG Xiaoling、 RAMOS Alex H.、 CHEAH Jaime H.、 CLEMONS Paul A.、 WARMUTH Markus、 ZHU Ping、 SHAMJI Alykhan F.、 SCHREIBER Stuart L.

IMS-P6

Identification, Synthesis of Novel and Potent Series of Pyrazolo[3,4-d]pyrimidine as GPR119 Agonist

Identification, Synthesis of Novel and Potent Series of Pyrazolo[3,4-d]pyrimidine as GPR119 Agonist

シンポジスト： ○SAHA Goutam、 GILLESPIE Paul、 GOODNOW Jr Robert A.、 BOSE Gopal、 MOULIK Kakali、 ZWINGELSTEIN Catherine、 MYERS Michael、 CONDE-KNAPE Karin、 PIETRANICAO-COLE Sherrie、 SO Sung-Sau

IMS-P7

Identification of Pharmacophore of the Natural Isoflavone Lead as Interleukin-5 Antagonist for Novel Anti-Allergic Drug

Identification of Pharmacophore of the Natural Isoflavone Lead as Interleukin-5 Antagonist for Novel Anti-Allergic Drug

シンポジスト： KIM Dong-Hyun、 BOGGU PullaReddy、 MANICKAM Manoj、 RAO Eeda Venkateswara、 KIM Youngsoo、 ○JUNG Sang-Hun

IMS-P8

CPZEN-45, as a Promising Drug Candidate for Treating Extremely Drug-Resistant Tuberculosis (XDR-TB): Synthesis, Activity and Mode of Action

CPZEN-45, as a Promising Drug Candidate for Treating Extremely Drug-Resistant Tuberculosis (XDR-TB): Synthesis, Activity and Mode of Action

シンポジスト： ○SASAKI Kazushige、 ISHIZAKI Yoshimasa、 TAKAHASHI Yoshiaki、 IGARASHI Masayuki、 MIYAKE Toshiaki、 OKADA Masaji、 DOI Norio、 BRENNAN Patrick J.、 AKAMATSU Yuzuru、 NOMOTO Akio

IMS-P9

Structure?Activity Relationship Studies and Synthesis of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517

Structure?Activity Relationship Studies and Synthesis of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517

シンポジスト： ○KUROSE Noriyuki、 TAFESSE Laykea、 KANEMASA Toshiyuki、 YU Jianming、 ASAKI Toshiyuki、 WU Gang、 IWAMOTO Yuka、 YAMAGUCHI Yoshitaka、 NI Chiyou、 ENGEL John、 TSUNO Naoki、 HORIGUCHI Tohru、 PATEL Aniket、 ZHOU Xiaoming、 SHINTANI Takuya、 BROWN Kevin、 HASEGAWA Tsuyoshi、 SHET Manjunath、 ISO Yasuyoshi、 KATO Akira、 KYLE Donald J.

IMS-P10

Design, Synthesis and Structure?Activity Relationships of 5-alkylaminoquinolines: Potent, Orally Active Corticotropin-Releasing Factor-1 Receptor Antagonists

Design, Synthesis and Structure?Activity Relationships of 5-alkylaminoquinolines: Potent, Orally Active Corticotropin-Releasing Factor-1 Receptor Antagonists

シンポジスト： ○TAKEDA Kunitoshi、 TERAUCHI Taro、 HASHIZUME Minako、 SHIKATA Kohdoh、 TAGUCHI Ryota、 MURATA-TAI Kaoru、 FUJISAWA Masae、 TAKAHASHI Yoshinori、 SHIN Kogyoku、 INO Mitsuhiro、 SHIBATA Hisashi、 YONAGA Masahiro

IMS-P11

Benzo[b]tellurophene and Benzo[b]selenophene Compounds as Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitors

Benzo[b]tellurophene and Benzo[b]selenophene Compounds as Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitors

シンポジスト： KIM Yoon-Jung、 LEE Dong Hoon、 CHOI Yong-Sung、 KWON So Hee、 ○JEONG Jin-Hyun

IMS-P12

Amphipathic Double-Stapled Helices as Antimicrobial Peptides

Amphipathic Double-Stapled Helices as Antimicrobial Peptides

シンポジスト： DINH Thuy T. T.、 KIM Do-Hee、 LEE Bong-Jin、 ○KIM Young-Woo

IMS-P13

Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human Cells

Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human Cells

シンポジスト： ○KAMBE Tohru、 CORREIA Bruno E.、 NIPHAKIS Micah J.、 CRAVATT Benjamin F.

IMS-P14

Optimization of Therapeutic Phosphorothioate Oligonucletides by P-Chirality Control

Optimization of Therapeutic Phosphorothioate Oligonucletides by P-Chirality Control

シンポジスト： ○IWAMOTO Naoki

IMS-P15

Discovery of a Novel and Potent γ-Secretase Modulator, E2012, for the Treatment of Alzheimer's Disease

Discovery of a Novel and Potent γ-Secretase Modulator, E2012, for the Treatment of Alzheimer's Disease

シンポジスト： ○KIMURA Teiji、 DOI Eriko、 KAWANO Koki、 ITO Koichi、 KITAZAWA Noritaka、 KANEKO Toshihiko、 TAKAISHI Mamoru、 SHIN Kougyoku、 SASAKI Takeo、 ARAKI Shin、 ISHIBASHI Akira、 WATANABE Hideki、 MURATA Yoshiyuki、 AOYAGI Hirofumi、 HAGIWARA Hiroaki、 OGASAWARA Aichi、 BERNIER Francois、 HASHIMOTO Toshihide、 AMINO Hiroyuki、 TAKAKUWA Susumu、 YOSHIZAWA Kyoko、 MIYAGAWA Takehiko

IMS-P16

Intervenolin, a New Antitumor Compound with Anti-Helicobacter pylori Activity, from Nocardia sp. ML96-86F2

Intervenolin, a New Antitumor Compound with Anti-Helicobacter pylori Activity, from Nocardia sp. ML96-86F2

シンポジスト： ○KAWADA Manabu、 INOUE Hiroyuki、 OHBA Shun-ichi、 ABE Hikaru、 HATANO Masaki、 AMEMIYA Masahide、 HAYASHI Chigusa、 USAMI Ihomi、 YOSHIDA Junjiro、 WATANABE Takumi、 IGARASHI Masayuki、 MASUDA Tohru、 SHIBASAKI Masakatsu、 NOMOTO Akio

IMS-P17

ASP2215, a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Acute Myeloid Leukemia

ASP2215, a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Acute Myeloid Leukemia

シンポジスト： ○UENO Yoko、 KANEKO Naoki、 MORI Masamichi、 TANAKA Ruriko、 SAITO Rika、 SHIMADA Itsuro、 KUROMITSU Sadao

IMS-P18

Pharmacological Evaluation of ASP8273, a Mutant-Selective Irreversible EGFR Inhibitor for EGFR Activating Mutations and T790M Resistance Mutation

Pharmacological Evaluation of ASP8273, a Mutant-Selective Irreversible EGFR Inhibitor for EGFR Activating Mutations and T790M Resistance Mutation

シンポジスト： ○KONAGAI Satoshi、 SAKAGAMI Hideki、 YAMAMOTO Hiroko、 TANAKA Hiroaki、 MATSUYA Takahiro、 MORI Masamichi、 KOSHIO Hiroyuki、 YURI Masatoshi、 HIRANO Masaaki、 KUROMITSU Sadao

IMS-P19

Discovery of a Novel and Potent Dual Orexin 1/Orexin 2 Receptor Antagonist, E2006, for the Treatment of Sleep Disorders

Discovery of a Novel and Potent Dual Orexin 1/Orexin 2 Receptor Antagonist, E2006, for the Treatment of Sleep Disorders

シンポジスト： ○YOSHIDA Yu、 TERAUCHI Taro、 NAOE Yoshimitsu、 KAZUTA Yuji、 OZAKI Fumihiro、 TAKEMURA Ayumi、 DOKO Takashi、 TANAKA Toshiaki、 SORIMACHI Keiichi、 BEUCKMANN Carsten T.、 NAKAGAWA Makoto、 SUZUKI Michiyuki、 AKASOFU Shigeru、 KUSHIDA Ikuo、 OZAKI Shunsuke、 TAKENAKA Osamu、 UENO Takashi

IMS-P20

Discovery of TAK-063, a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor

Discovery of TAK-063, a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor

シンポジスト： ○YOSHIKAWA Masato、 KUNITOMO Jun、 FUSHIMI Makoto、 KAWADA Akira、 QUINN John F.、 OKI Hideyuki、 KOKUBO Hironori、 KONDO Mitsuyo、 NAKASHIMA Kosuke、 KAMIGUCHI Naomi、 SUZUKI Kazunori、 KIMURA Haruhide、 TANIGUCHI Takahiko

IMS-P21

Discovery of ASP5736, a Novel 5-HT_5A Receptor Antagonist as an Antipsychotic Drug

Discovery of ASP5736, a Novel 5-HT_5A Receptor Antagonist as an Antipsychotic Drug

シンポジスト： ○KINOYAMA Isao、 HAMAGUCHI Wataru、 MIYAZAKI Takehiro、 KOGANEMARU Yohei、 WASHIO Takuya、 KANEKO Osamu、 KAWAMOTO Yuichiro、 YAMAZAKI Mayako、 FUJII Masahiro、 WATANABE Toshihiro

IMS-P22

Discovery of Amenamevir (ASP2151), a Helicase-Primase Inhibitor as an Antiviral Drug against Varicella-Zoster Virus and Herpes Simplex Virus Types 1 and 2

Discovery of Amenamevir (ASP2151), a Helicase-Primase Inhibitor as an Antiviral Drug against Varicella-Zoster Virus and Herpes Simplex Virus Types 1 and 2

シンポジスト： ○HAMAGUCHI Wataru、 KONTANI Toru、 MIYATA Junji、 HONDA Shugo、 SUZUKI Hiroshi、 TAKEUCHI Makoto

IMS-P23

S-649266, a Novel Siderophore Cephalosporin Antibiotic: Its Potent Activity against Multidrug-Resistant Gram-Negative Bacteria

S-649266, a Novel Siderophore Cephalosporin Antibiotic: Its Potent Activity against Multidrug-Resistant Gram-Negative Bacteria

シンポジスト： ○ITO Akinobu、 NISHIKAWA Toru、 MATSUMOTO Shuhei、 HORIYAMA Tsukasa、 KOHIRA Naoki、 YOSHIZAWA Hidenori、 NAKAMURA Rio、 TSUJI Masakatsu、 YAMANO Yoshinori

IMS-P24

Identification of 5-HT6 Antagonists without a Basic Amine Moiety

Identification of 5-HT6 Antagonists without a Basic Amine Moiety

シンポジスト： GUZZO Peter R.、 KITCHEN Douglas B.、 GHOSH Animesh、 ○ISHERWOOD Matthew L.、 KAUR Jagjit、 KHMELNITSKY Yuri、 KOO Jia Man、 LEE Chong Yew、 LUCHE Michele、 NARREDDULA Venkateswara Reddy、 MHYRE Andrew、 MOORE Nicholas、 PANDUGA Shailaja、 RYAN Kristen、 ZHAO He (River)、 SWAMINATHAN Srividya、 TAN Valentina、 WIERSCHKE Jonathan、 XIANG Kai、 ZHU Qiang、 HENDERSON Alan J.

IMS-P25

Research and Development of Novel Anti-Cancer Drug Mogamulizumab, Humanized Anti-CCR4 Antibody Using High ADCC POTELLIGENT^R Technology, for Adult T-Cell Leukemia-Lymphoma

Research and Development of Novel Anti-Cancer Drug Mogamulizumab, Humanized Anti-CCR4 Antibody Using High ADCC POTELLIGENT^R Technology, for Adult T-Cell Leukemia-Lymphoma

シンポジスト： ○NAKAMURA Kazuyasu、 SHITARA Kenya、 MATSUSHIMA Kouji、 AKINAGA Shiro、 UEDA Ryuzo

検索ページに戻る